ROSSINI, Maurizio
 Distribuzione geografica
Continente #
EU - Europa 21.660
NA - Nord America 18.975
AS - Asia 14.064
SA - Sud America 2.026
AF - Africa 258
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 16
Totale 57.034
Nazione #
US - Stati Uniti d'America 18.671
RU - Federazione Russa 7.735
SG - Singapore 6.085
GB - Regno Unito 5.331
CN - Cina 4.339
IT - Italia 2.018
BR - Brasile 1.657
DE - Germania 1.350
HK - Hong Kong 1.330
FR - Francia 1.224
SE - Svezia 1.106
IE - Irlanda 1.050
FI - Finlandia 851
VN - Vietnam 806
KR - Corea 402
UA - Ucraina 299
IN - India 227
TR - Turchia 202
JP - Giappone 168
CA - Canada 148
NL - Olanda 134
AR - Argentina 131
PL - Polonia 107
MX - Messico 104
ES - Italia 94
BD - Bangladesh 90
ID - Indonesia 79
BE - Belgio 74
AT - Austria 72
IQ - Iraq 63
EC - Ecuador 61
ZA - Sudafrica 61
RO - Romania 43
TG - Togo 42
BJ - Benin 40
CO - Colombia 39
CL - Cile 37
IR - Iran 35
VE - Venezuela 35
UZ - Uzbekistan 31
AU - Australia 28
PK - Pakistan 25
MA - Marocco 24
PY - Paraguay 24
EG - Egitto 23
NP - Nepal 21
CH - Svizzera 18
PE - Perù 17
CZ - Repubblica Ceca 16
KE - Kenya 16
LT - Lituania 16
AE - Emirati Arabi Uniti 15
IL - Israele 15
AZ - Azerbaigian 14
GR - Grecia 14
SA - Arabia Saudita 14
SK - Slovacchia (Repubblica Slovacca) 13
JO - Giordania 12
PT - Portogallo 12
DZ - Algeria 11
UY - Uruguay 11
BG - Bulgaria 10
BO - Bolivia 10
HR - Croazia 10
AL - Albania 9
TN - Tunisia 9
DO - Repubblica Dominicana 8
EU - Europa 8
JM - Giamaica 8
KG - Kirghizistan 8
BH - Bahrain 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AM - Armenia 6
CR - Costa Rica 6
HN - Honduras 6
MY - Malesia 6
OM - Oman 6
PH - Filippine 6
SN - Senegal 6
TH - Thailandia 6
DK - Danimarca 5
KW - Kuwait 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
QA - Qatar 5
BW - Botswana 4
BY - Bielorussia 4
EE - Estonia 4
GE - Georgia 4
HU - Ungheria 4
IS - Islanda 4
KZ - Kazakistan 4
LB - Libano 4
LK - Sri Lanka 4
MK - Macedonia 4
NO - Norvegia 4
PA - Panama 4
RS - Serbia 4
SI - Slovenia 4
Totale 56.957
Città #
Southend 4.776
Singapore 2.946
Moscow 2.479
Jacksonville 2.237
Chandler 2.205
Dallas 1.998
Ashburn 1.430
Hong Kong 1.312
Woodbridge 1.234
Dublin 1.034
Ann Arbor 959
Beijing 700
Houston 692
Lawrence 447
Princeton 447
Wilmington 423
Los Angeles 408
The Dalles 401
New York 394
Jinan 329
Nanjing 296
Shenyang 280
Ho Chi Minh City 274
Verona 250
Redmond 238
Buffalo 219
Bologna 207
Helsinki 199
Milan 197
Tianjin 179
Sindelfingen 178
Hebei 175
Munich 167
Redondo Beach 159
Hanoi 154
Tokyo 153
São Paulo 149
Changsha 136
Columbus 129
Ningbo 113
Zhengzhou 112
Boardman 109
Haikou 109
Nanchang 108
Santa Clara 95
Hangzhou 94
Jiaxing 90
Warsaw 90
Taizhou 88
Rome 86
Seattle 86
Guangzhou 84
London 81
Denver 76
Redwood City 72
Taiyuan 69
San Francisco 67
Brussels 65
Chicago 65
Falkenstein 65
Norwalk 65
Brooklyn 58
Turku 58
Washington 57
Falls Church 51
Orem 49
Fairfield 48
Belo Horizonte 47
Hyderabad 47
Johannesburg 45
Phoenix 45
Toronto 44
Fuzhou 43
Montreal 43
Rio de Janeiro 43
Vienna 43
Dearborn 42
Jakarta 42
Lanzhou 42
Lomé 42
Brasília 41
Dong Ket 41
Cotonou 40
Orani 40
Seoul 39
Atlanta 38
Boston 38
Poplar 38
Stockholm 38
Chennai 37
Amsterdam 36
Mexico City 34
Manchester 32
Frankfurt am Main 31
Biên Hòa 30
Düsseldorf 30
Nuremberg 30
Da Nang 29
San Jose 29
Tashkent 29
Totale 34.068
Nome #
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 407
Epidemiology and Economic Burden of Osteoporosis in Italy 392
Teriparatide and denosumab combination therapy and skeletal metabolism 313
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 302
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology-Rheumatology Clinic: A 24-Week Multicenter Study 285
Artrite Reumatoide e Metabolismo Minerale 246
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 242
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 229
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 229
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 226
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 222
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 215
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 212
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 212
Anti-CCP antibodies and bone 209
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 207
Age-related bone loss in postmenopausal women 207
[Therapeutic strategies in osteoporosis: whom and when to treat] 205
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 203
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 202
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 202
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 200
Bone metabolism in patients with anorexia nervosa and amenorrhoea 198
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 196
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 195
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 194
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 194
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 192
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 190
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 188
[Risk factors for hip fracture in elderly persons]. 188
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 187
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 184
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 182
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 181
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 180
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 180
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 180
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 178
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 178
Bone involvement and osteoporosis in mastocytosis. 176
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 176
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 175
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 173
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 171
Could γ\δ T-cells explain zoledronic acid adverse events? 169
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 169
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 169
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 168
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 167
Bone involvement in patient with clonal mast cell disorders 166
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 166
Incidenza di ipovitaminosi D nel Nord Italia 165
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 165
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 164
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 161
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 161
Allergy and the bone: unexpected relationships 160
Prevalence and incidence of rheumatoid arthritis in Italy. 160
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 160
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 159
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 159
Guidelines for the diagnosis, prevention and management of osteoporosis 159
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 157
Rapporti tra sistema immune e metabolismo osseo 157
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 157
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 156
A multi-dimensional questionnaire quantifying quality of life in elderly osteoporotic women: the Italian triple-Q osteoporosis study 155
ARTROPATIE DISMETABOLICHE 155
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 155
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases. 153
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 152
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 152
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 152
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 151
DXA bone mineral density in males: retrospective study in real life. 150
Osteoporosis treatment: why ibandronic acid? 150
Artropatie degenerative 148
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 148
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 148
Bone Disease in Mastocytosis 148
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 148
Effects of denosumab on peripheral lymphocyte subpopulations 148
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 148
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 146
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 146
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 146
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 145
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 145
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 144
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 144
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 144
Prevalence of osteoporosis in patients affected by mastocytosis 143
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 141
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 141
Safety issues and adverse reactions with osteoporosis management 141
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 141
Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis 141
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 140
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 140
Totale 18.026
Categoria #
all - tutte 200.633
article - articoli 191.916
book - libri 0
conference - conferenze 2.855
curatela - curatele 0
other - altro 585
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.277
Totale 401.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.680 0 0 0 0 0 425 82 242 306 27 440 158
2021/20223.269 238 807 49 158 155 128 61 185 278 97 305 808
2022/20236.835 560 555 703 1.180 607 1.652 86 384 732 75 226 75
2023/20243.514 179 270 330 418 403 534 180 274 58 128 494 246
2024/20259.554 564 679 406 1.475 472 257 444 469 1.414 810 701 1.863
2025/202618.039 1.946 1.344 2.236 4.372 6.500 1.641 0 0 0 0 0 0
Totale 57.815